Literature DB >> 2881817

Distribution and activation of protein kinase C in the rat testis tissue.

H Nikula, Z Naor, M Parvinen, I Huhtaniemi.   

Abstract

The distribution and role of the calcium-activated, phospholipid-dependent protein kinase C (PK-C) was studied in rat testis. When testis tissue was homogenized in the presence of 2 mmol/l EDTA and EGTA, the majority (greater than 70%) of the PK-C activity was soluble, the rest was released from the particulate fraction by solubilization with 0.3% Triton X-100. Without chelating agents the soluble PK-C activity was undetectable, and only partially recovered from solubilized membranes. Preincubation of the tissue with the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA, 10(-7) mol/l) translocated PK-C to the membranes, and the majority of this activity was recovered by solubilization. Mobility of testicular soluble PK-C activity in HPLC-DEAE cellulose chromatography was similar to that of the brain enzyme. This single step purified testicular PK-C activity 140-fold. The specific activity and subcellular distribution of PK-C was similar in whole testis tissue and separated seminiferous tubules (160-210 pmol 32P X mg protein-1 X min-1 in the soluble and particulate fractions), but 2- to 3-fold higher in purified Leydig cells. However, the majority of total testicular PK-C activity appeared to be of tubular origin. Unilateral cryptorchidism for 1 week reduced PK-C of the abdominal testis by 50%, and the activity of dissected seminiferous tubules varied according to the epithelial wave. Both findings suggest that the bulk of the activity resides in the seminiferous epithelium. Involvement of PK-C in Leydig cell function was demonstrated using the TPA, which at 10(-7) mol/l inhibited basal cAMP production by 50% (P less than 0.01) but increased that of testosterone by 2- to 3-fold (P less than 0.01). On the other hand, when incubated with hCG, TPA inhibited both cAMP and testosterone production; the ED50s of hCG stimulation increased 4- to 10-fold with both parameters. It is concluded that PK-C activity is present in both the seminiferous tubules and Leydig cells, and is involved in the regulation of these testicular compartments. Its total activity and subcellular distribution are at variance according to the functional state and endocrine milieu of the testis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881817     DOI: 10.1016/0303-7207(87)90062-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Similarities and differences in phorbol ester- and luteinizing-hormone-induced desensitization of rat tumour Leydig-cell adenylate cyclase.

Authors:  C J Dix; A D Habberfield; B A Cooke
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Polyunsaturated fatty acids do not activate protein kinase C in the testis of the goldfish (Carassius auratus).

Authors:  M G Wade; P M Jacobson; G Van Der Kraak
Journal:  Fish Physiol Biochem       Date:  1994-05       Impact factor: 2.794

3.  Protein kinase C is present in human sperm: possible role in flagellar motility.

Authors:  R Rotem; G F Paz; Z T Homonnai; M Kalina; Z Naor
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  LH/hCG-receptor is coupled to both adenylate cyclase and protein kinase C signaling pathways in isolated mouse Leydig cells.

Authors:  J U Würthner; M Kistler; M Kratzmeier; A K Mukhopadhyay
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

5.  Modulation of testicular galactolipid sulphotransferase activity by phosphorylation. Stimulation of enzyme activity in vitro by an endogenous kinase.

Authors:  D Sakac; C A Lingwood
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

Review 6.  Pathophysiology of cell phone radiation: oxidative stress and carcinogenesis with focus on male reproductive system.

Authors:  Nisarg R Desai; Kavindra K Kesari; Ashok Agarwal
Journal:  Reprod Biol Endocrinol       Date:  2009-10-22       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.